Bringing doctors together

or

A free, private network for verified physicians

  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    PSDr. Paul Sax
    Leading Voice

    Dr. Paul Sax

    Infectious Disease · General Infectious Disease
    Brigham and Women's Hospital
    pauls
    Boston, MA, USA
    Sep 2, 2026Journal Article

    Hypertension in a Randomized Trial of Dolutegravir- Versus Efavirenz-Based Antiretroviral Therapy in Pregnant and Postpartum Women with HIV.

    ​

    Written by 1 Roon author & 23 others

    Via Clinical Infectious Diseases
    Sep 1, 2026Journal Article

    A Duty to Act.

    ​
    ​

    Written by 2 Roon authors & 14 others

    Via Clinical Infectious Diseases

    Research

    Weight Trajectories in Virally Suppressed People With HIV Compared With Matched People Without HIV, and Predictors of Weight Gain: A 3-Year Cohort Study From the US TRIO Healthcare Network

    2026

    Via J Acquir Immune Defic Syndr

    Apr 30, 2026Journal Article

    Protocols for Randomized Controlled Trials: Advancing Transparency in Infectious Diseases.

    ​

    Written by 1 Roon author & 3 others

    Via Clinical Infectious Diseases

    Research

    People with HIV Continuing on Complex Regimens in the Era of Treatment Optimization: Characteristics and Outcomes

    2026

    Via AIDS Patient Care STDS

    Research

    Ten-Year Cost Projections for Medicare Beneficiaries 65 Years or Older With HIV

    2026

    Via JAMA Netw Open

    Jul 23, 2026Journal Article

    Is 2-Drug Therapy With Dolutegravir and Lamivudine an Appropriate Option for People With HIV and Historic Lamivudine Resistance?

    ​

    Written by 1 Roon author & 2 others

    Via Clinical Infectious Diseases
    Sep 2, 2026Journal Article

    Understanding the Clinical Implications of the Barrier Against Resistance in Antiretroviral Treatment.

    ​

    Written by 1 Roon author & 8 others

    Via Clinical Infectious Diseases
    Sep 10, 2026Correspondence

    Ensitrelvir for Covid-19 Postexposure Prophylaxis

    Via The New England Journal of Medicine

    Research

    Melanocortin-4 Receptor Gene Variants and Weight Change Following Switch to Integrase Inhibitor-Based Antiretroviral Therapy

    2025

    Via Open Forum Infect Dis

    Mar 17, 2025Clinical Trial, Phase III

    Lipid and Glucose Profiles in Pregnant Women With HIV on Tenofovir-based Antiretroviral Therapy.

    ​

    Written by 1 Roon author & 20 others

    Via Clinical Infectious Diseases
    Feb 5, 2025Journal Article

    Lower Mortality Risk Associated With Remdesivir + Dexamethasone Versus Dexamethasone Alone for the Treatment of Patients Hospitalized for COVID-19.

    ​

    Written by 1 Roon author & 10 others

    Via Clinical Infectious Diseases

    Research

    Long-Acting Cabotegravir Plus Rilpivirine in People With HIV With Adherence Challenges and Viremia: Current Data and Future Directions

    2025

    Via Clinical Infectious Diseases

    Research

    Efficacy of bictegravir/emtricitabine/tenofovir alafenamide versus dolutegravir-based three-drug regimens in people with HIV with varying adherence to antiretroviral therapy

    2025

    Via The Journal of Antimicrobial Chemotherapy

    Research

    Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society-USA Panel

    2025

    Via JAMA